New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...
allAfrica.com on MSN
Africa: Phase 2 Clinical Trial Results Show Potential to Shorten TB Treatment Time
Sorfequiline, previously known as TBAJ-876, was evaluated in combination with pretomanid and linezolid in a randomized, controlled trial in people with drug-sensitive TB ...
News-Medical.Net on MSN
New clinical trial shows promise for shorter TB treatment
New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...
Positive results mark an important step forward in efforts to develop effective treatments for children with drug-resistant TB COPENHAGEN, Denmark, Nov. 19, 2025 /PRNewswire/ -- New interim data from ...
Science Africa on MSN
TB Treatment Can be Shortened, Clinical Trial Shows
By Sharon Atieno With tuberculosis (TB) treatment lasting about six to nine months, a new treatment regimen is set to reduce this period.A phase two clinical trial by TB Alliance has showed that a new ...
An international team of investigators today announced promising data from a trial of a novel antibiotic that could ...
Much of the current antimicrobial resistance (AMR) crisis in India is driven by overuse of common antibiotics like ...
Early clinical trial results show that the new antibiotic sorfequiline, used in the SPaL regimen, demonstrated stronger ...
The recently released Global TB Report 2025 shows that although the burden of tuberculosis in India continues to decline, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback